Loading company…
Waltham-based spatial genomics company whose MERSCOPE Ultra platform performs high-plex single-cell analysis.
Vizgen, Inc., founded in 2019 and based in Waltham, US, makes spatial genomics tools, led by the MERSCOPE Ultra, a high-plex, in situ single-cell platform based on MERFISH technology. The platform automates imaging, analysis, and cell segmentation and supports custom panels of up to 1,000 genes. Research institutions and academic labs in neuroscience and cancer research are its main customers. In January 2025 the company raised USD 48 million in venture funding led by ARCH Venture Partners, with Northpond Ventures and M Ventures co-leading.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in